Literature DB >> 2358329

Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx.

F C Candela1, K Kothari, J P Shah.   

Abstract

A retrospective review of 333 previously untreated patients from 1965 to 1986, with primary squamous cell carcinoma of the oropharynx or hypopharynx, was undertaken to ascertain the prevalence of neck node metastases by neck level. The 333 patients underwent 344 classical radical neck dissections. Patients were grouped by clinical neck status at the time of neck dissection: elective dissection in the N0 neck (N = 71), and immediate therapeutic dissection in the N+ neck (N = 259). Detailed analysis was performed for each group based on the specific primary site. This revealed a predominance of neck node metastases in levels II, III, and IV for both oropharyngeal and hypopharyngeal primaries. Isolated "skip" metastases outside of levels II, III, or IV occurred in only 1 patient (0.3%). Otherwise, level I or V involvement was always associated with nodal metastases at other levels (ie, N2 disease). These data support the trend toward selective limited neck dissection (anterior modified) in N0 patients. Furthermore, they provide the foundation for planning of future prospective trials to assess the efficacy of modifications in the extent of neck dissection for carcinomas of the oropharynx or hypopharynx.

Entities:  

Mesh:

Year:  1990        PMID: 2358329     DOI: 10.1002/hed.2880120302

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  31 in total

1.  A rule-based model for local and regional tumor spread.

Authors:  Ira J Kalet; Mark Whipple; Silvia Pessah; Jerry Barker; Marry M Austin-Seymour; Linda G Shapiro
Journal:  Proc AMIA Symp       Date:  2002

2.  Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.

Authors:  Sandra Schmitz; Jean-Pascal Machiels; Birgit Weynand; Vincent Gregoire; Marc Hamoir
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-22       Impact factor: 2.503

3.  Selective neck dissection in the management of squamous cell carcinoma of the upper digestive tract.

Authors:  P Ambrosch; L Freudenberg; M Kron; W Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 4.  Surgery Versus Radiotherapy for Early Oropharyngeal Tumors: a Never-Ending Debate.

Authors:  Yan Monnier; Christian Simon
Journal:  Curr Treat Options Oncol       Date:  2015-09

5.  Comparison of the efficacy of clinical examination, ultrasound neck and computed tomography in detection and staging of cervical lymph node metastasis in head and neck cancers.

Authors:  Nitin Anand; Neena Chaudhary; M K Mittal; Rajni Prasad
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-04-26

Review 6.  Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx.

Authors:  R Böscke; B D Cakir; A S Hoffmann; S Wiegand; J Quetz; J E Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-10       Impact factor: 2.503

7.  Biological Model Development as an Opportunity to Provide Content Auditing for the Foundational Model of Anatomy Ontology.

Authors:  Lucy L Wang; Eli Grunblatt; Hyunggu Jung; Ira J Kalet; Mark E Whipple
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

Review 8.  The impact of patterns of nodal metastasis on modifications of neck dissection.

Authors:  J P Shah; P E Andersen
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

9.  Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Authors:  Janice L Farlow; Andrew C Birkeland; Andrew J Rosko; Kyle VanKoevering; Catherine T Haring; Joshua D Smith; J Chad Brenner; Andrew G Shuman; Steven B Chinn; Chaz L Stucken; Kelly M Malloy; Jeffrey S Moyer; Keith A Casper; Scott A McLean; Mark E P Prince; Carol R Bradford; Gregory T Wolf; Douglas B Chepeha; Matthew E Spector
Journal:  Ann Surg Oncol       Date:  2019-03-04       Impact factor: 5.344

10.  Level 5 Lymphadenopathy Warrants Heightened Suspicion for Clinically Significant Pathology.

Authors:  M Cunnane; L Cheung; A Moore; S di Palma; A McCombe; L Pitkin
Journal:  Head Neck Pathol       Date:  2016-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.